glp 1 drugs for inflammation GLP-1 Medications Arthritis & Autoimmune Disease The GLP-1 Era: Why These

Every compound in this class, from semaglutide to tirzepatide to these newer agents, causes nausea, vomiting, and diarrhea to some degree

Cognition improved in exenatide treated patients in fluid intelligence (baseline 38.4 (8.2), 12 weeks 52.9 (6.6), p = 0.0005), processing speed (baseline 43.7 (9.4), 12 weeks 58.4 (10.4), p = 0.0058) and episodic memory (baseline 49.4 (5.3), 12 weeks 62.1 (13.2), p = 0.0315)

Then you'll see your doctor at regular intervals so they can monitor you for side effects, track your progress, and monitor for any potential adverse effects

However, the outcome can vary depending on individual factors such as diet and exercise

No single therapy addresses all hallmarks

Each woman taking GLP-1 drugs was matched with a woman not taking the drugs, based on factors such as age, race, ethnicity, BMI, breast density, and diabetes status